A
Strong scientific evidence
- Iodine
:
Potassium iodide (KI) can be given in cases of radiation exposure to block radioactive iodine uptake by the thyroid. This may reduce the risk of developing thyroid cancer in the future. Potassium iodide does not provide immediate protection from radiation damage, and does not have protective effects against other radiation exposure complications.
B
Good scientific evidence
- Calendula
:
One study in women receiving radiation therapy for breast cancer reports that calendula ointment applied to the skin at least twice daily during treatment reduces the number of people experiencing the following severe dermatitis symptoms (skin irritation, redness, and pain). However, based on study design limitations, the evidence cannot be considered conclusive. Evidence suggests that calendula ointment may be considered in patients who experience radiation dermatitis that cannot be controlled with other therapies.
- Probiotics
:
One study suggests that Lactobacillus rhamnosus may aid in reducing symptoms of radiation-induced diarrhea in patients receiving radiotherapy for cancer in the abdomen and pelvis.
C
Unclear or conflicting scientific evidence
D
Fair negative scientific evidence
- Aloe
:
Reports during the 1930s of topical aloe's beneficial effect on post-radiation dermatitis triggered widespread use in dermatologic and cosmetic products. Some practitioners recommend aloe gel for radiation-induced dermatitis. However, preliminary scientific evaluation suggests that topical aloe may not significantly improve pain or desquamation (shedding of the outer layer of skin) related to radiotherapy. Additional well-designed studies are necessary before a firm conclusion can be drawn.
- Pantothenic acid
:
One study reported that skin application of dexpanthenol, an analog of pantothenic acid, to areas of skin treated with radiation does not appear to reduce erythema (redness of the skin), desquamation (shedding of the outer layer of skin), itching, or pain following treatment.
- Sweet almond
:
One methodologically weak human trial reported that topical almond ointment was not beneficial to the skin of breast cancer patients receiving radiotherapy.